| scholarly article | Q13442814 |
| P50 | author | Jehyung Hwang | Q88003448 |
| P2093 | author name string | Jae Yong Park | |
| Jae Suk Kim | |||
| Bum Gi Kim | |||
| P2860 | cites work | Acidic mammalian chitinase in dry eye conditions. | Q54478327 |
| Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. | Q54643325 | ||
| Dry Eye–Induced Conjunctival Epithelial Squamous Metaplasia Is Modulated by Interferon-γ | Q61851323 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye | Q24794134 | ||
| Dry eye: an inflammatory ocular disease | Q26852044 | ||
| Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A | Q28316169 | ||
| Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. | Q30813799 | ||
| Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years | Q34443357 | ||
| Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. | Q34544207 | ||
| Physiology and pathophysiology of matrix metalloproteases. | Q35007715 | ||
| Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease | Q35197785 | ||
| A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's Syndrome International Registry | Q36283986 | ||
| IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways | Q36665694 | ||
| Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome | Q36676823 | ||
| Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients. | Q36829070 | ||
| CD8⁺ cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome | Q37407580 | ||
| Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease. | Q38171801 | ||
| The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye | Q38724515 | ||
| IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression | Q39823663 | ||
| Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. | Q41005189 | ||
| Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease | Q43723395 | ||
| Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface | Q45158772 | ||
| Inflammation in dry eye. | Q46372528 | ||
| Mitochondrial DNA oxidation induces imbalanced activity of NLRP3/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye. | Q46412408 | ||
| Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay | Q47374338 | ||
| Correlation of Tear Film Osmolarity and 2 Different MMP-9 Tests With Common Dry Eye Tests in a Cohort of Non-Dry Eye Patients. | Q50279252 | ||
| Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. | Q50721017 | ||
| Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. | Q51112094 | ||
| IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. | Q51970072 | ||
| Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. | Q52250855 | ||
| Utility assessment among patients with dry eye disease. | Q53379868 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 31 | |
| P577 | publication date | 2018-09-01 | |
| P1433 | published in | Translational vision science & technology | Q27724547 |
| P1476 | title | Matrix Metalloproteinase 9 Point-of-Care Immunoassay Result Predicts Response to Topical Cyclosporine Treatment in Dry Eye Disease | |
| P478 | volume | 7 |
Search more.